CAS: 264234-05-1; (R,E)-4-((6,7-Dihydroxy-3,7-Dimethyloct-2-En-1-yl)Oxy)-7H-Furo[3,2-G]Chromen-7-One

该化合物是一种主要存在于葡萄园和白酒中的生物活性呋喃衍生物,以其作为细胞色素P450酶,特别是影响药物新陈代谢的CYP3A4的强大抑制剂的作用而著称,该化合物因其能够调节共同管理药物的生物利用性而对药理动力学研究非常感兴趣,其结构特征,包括六尺七寸的氢氧基化合物群,有助于其抑制活动和与药物运输者的潜在互动,研究应用包括调查药物-药物相互作用和代谢途径,6'7'-二氢氧乙酸盐的分析标准用于临床前科和临床研究,以评估安全和效能概况.

结构式图片

上下游产品

CAS号486-60-2 香柑醇; 5-羟基-6,7-呋喃并香豆素

合成工艺路线路线简述

    📜6',7'-Dihydroxybergamottin octanal Acetal 反应生成6',7'-二羟薄荷素
    参考文献:葡萄柚皮油中的次要呋喃香豆素和香豆素可作为人类细胞色素p450 3A4的抑制剂
    标题:葡萄柚皮油中的次要呋喃香豆素和香豆素可作为人类细胞色素p450 3A4的抑制剂
    摘要:一种新的环状缩醛(1 Marmin的)(6',7'-二羟基-7-Geranyloxycoumarin),两个新的环状缩醛(5,6 6)',7'-Dihydroxybergamottin,和已知化合物marmin(2),从柚子皮油中分离出7-香叶烷氧基香豆素(3),佛手柑(4)和6',7'-二羟基佛手柑(7).测试了所有化合物对肠道细胞色素p450 3A4的抑制活性,肠道细胞色素p450 3A4是一种参与人体"葡萄柚/药物"相互作用的酶.香豆素(1-3)显示出可忽略的抑制活性,而呋喃香豆素(4-7)显示出强大的体外抑制活性,Ic 50值分别为2.42,0.13,0.27和1.58μm.
    Doi:10.1021/np900266M

    海关参考信息

    专利信息


    专利号:US-6613918-B1
    优先权日:2000-10-20
    标 题 :Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates
    发明人:SEEMAYER ROBERT; LIANG JACK
    权利人:BIOAVAILABILITY SYSTEMS LLC
    摘要:Ortho esters and ortho carbonates can be produced by alkylating esters and carbonates with, for example, the hexafluorophosphate salt of a trialkyl oxonium ion. The spiro species are useful intermediates in the synthesis of complex organic molecules. Synthetic pathways for the production of medically active compounds incorporates spiro ortho esters. Anti-first-pass effect materials are produced in high yield utilizing a synthetic strategy incorporating cyclic ortho ester intermediates.

    专利号:WO-2004037827-A1
    优先权日:2000-10-20
    标题 :Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates

    专利号:US-6160006-A
    优先权日:1996-10-18
    标 题 :6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit
    发明人:EDWARDS DAVID J; WOSTER PATRICK M
    权利人:UNIV WAYNE STATE
    摘要:The present invention provides a composition and methods for inhibiting cytochrome P450 enzyme activity and in particular, inhibiting the activity of the cytochrome P450 3A sub-family of enzymes, specifically, CYP3A4. The present invention provides 6',7'-dihydroxybergamottin, a furanocoumarin, as the compound primarily responsible for the inhibitory effects of grapefruit juice on cytochrome P450 enzyme activity. The present invention also provides a novel synthesis scheme for 6',7'-dihydroxybergamottin.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.5281/zenodo.5794106
    摘要:The LOTUS Initiative for Open Natural Products Research: frozen dataset union wikidata (with metadata) | DOI:10.5281/zenodo.5794106
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知